Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial.

Autor: Drusano, George L., Yuen, Geoffrey J., Lambert, John S., Seidlin, Mindell, Dolin, Raphael, Valentine, Fred T., Drusano, G L, Yuen, G J, Lambert, J S, Seidlin, M, Dolin, R, Valentine, F T

Publikováno v: Annals of Internal Medicine; 4/1/92, Vol. 116 Issue 7, p562-566, 5p

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction

Autor: Heald, A E, Hsyu, P H, Yuen, G J, Robinson, P, Mydlow, P, Bartlett, J A

Publikováno v: Antimicrobial Agents and Chemotherapy; June 1996, Vol. 40 Issue: 6 p1514-1519, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.

Autor: Crémieux AC; Unité d'Investigation Clinique, H pital Bichat, Paris, France., Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F

Publikováno v: Pharmacotherapy [Pharmacotherapy] 2001 Apr; Vol. 21 (4), pp. 424-30.

Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.

Autor: Moore KH; Glaxo Wellcome Inc., Research Triangle Park, University of North Carolina at Chapel Hill, Chapel Hill, Durham, North Carolina 27709, USA. km10993@glaxowellcome.com, Yuen GJ, Hussey EK, Pakes GE, Eron JJ Jr, Bartlett JA

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 1999 Dec; Vol. 43 (12), pp. 3025-9.